Date

Tuesday, 08 November 2011

Location

European Medicines Agency, Amsterdam, the Netherlands

The general scope of this workshop is to share the experiences gained at the Paediatric Committee and the present approach in reviewing the appropriateness of paediatric formulations as part of paediatric investigation plans (PIPs). Registration closed.

Documents

Share this page